Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVS

CVS and Walgreens agree to pay $10 billion to settle lawsuits linked to opioid sales

CVS would pay about $5 billion and Walgreens more than $5.5 billion, though neither company has admitted wrongdoing. States have until the end of the year to accept the terms of the settlement.

WEKU

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

1 No-Brainer Stock to Buy When the Market Plunges

CVS Health (CVS) beat revenue and EPS estimates for the 2022 third quarter. Moreover, the stock has gained more than 10% over the past year despite the market turmoil. Also, it currently pays its shareholders a more than 2% dividend. Therefore, CVS might be an ideal buy amid challenging times.…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

How the best leaders are preparing to navigate a recession—and come out ahead

Current and former corporate leaders share their battle-tested playbooks with Fortune.

Fortune

You’ve got COVID — but what are the rules these days?

FORT LAUDERDALE, Fla. -- Someone at your office had COVID a few days ago and is now back at their desk in the cubicle next to yours. That can’t be okay, can it?

Tribune News Service

Varo Bank Review 2022: For the customer who prefers mobile banking and a 5.00% APY over the brick-and-mortar experience

Varo Bank offers only a few products, but for no-frills customers, this online-bank could be the right fit.

Fortune

3 Hot Stocks With More Room to Run in 2023

As inflation shows signs of easing and the Fed is expected to slow the pace of rate hikes, the market’s prospects look bright. Therefore, fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Box (BOX) could keep soaring. Wall Street analysts expect upsides in these stocks over the next 12…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Amazon vs Walmart: Who Has the Cheapest Prices?

Amazon handily beat Walmart for the lowest prices on food and consumables, a study shows. In other categories, things tightened up.

Kiplinger

4 Stocks That Can Help Fire up Your Portfolio This Winter

Recent data indicates the signs of slowing down inflation. Additionally, the Fed is leaning toward slowing its pace of rate hikes. Amid this, fundamentally strong stocks Johnson & Johnson (JNJ), CVS Health (CVS), Douglas Dynamics (PLOW), and Genie Energy (GNE) might be ideal additions to your portfolio this winter. Continue…

StockNews.com

How CEOs can lead in a recession and come out stronger: 5 powerful strategies from corner-office veterans

Battle-tested business leaders from CVS, Southwest Airlines, Honeywell and other Fortune 500 companies share their best ideas for navigating a downturn.

Fortune

Terrell Owens says man he punched at CVS threatened him, fan

Retired NFL star Terrell Owens said a fight caught on camera in which he punched a man in a CVS parking lot was the result of an “aggressor” threatening him and a fan he was talking to at the California store

The Independent UK

Delphi murders: What we know about suspect Richard Allen

Richard Allen is a married 50-year-old man who worked in the local CVS store in the heart of Delphi – where Libby German and Abby Williams lived with their families

The Independent UK

Why the tourniquet, a relic from the earliest days of medicine, is back amid the gun violence epidemic

PHILADELPHIA —The way the blood spurted from the bullet wound, Lt. Robert Friel knew he didn't have long.

The Philadelphia Inquirer

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Chicago Sun-Times

Be prepared: Surge of winter sickness likely on its way, city’s top doc says

If you haven’t had your COVID-19 fall 2022 booster, now is the time, Chicago Public Health Commissioner Dr. Allison Arwady said.

StockNews.com

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com

2 Dividend Stocks That Can See Your Portfolio Through Tough Times and Beyond

The market has been under pressure amid high inflation, rising interest rates, and a slowing economy. Amid lingering macro headwinds, dividend investing could help investors ensure a steady income stream. Therefore, quality dividend stocks, CVS Health (CVS) and Spok Holdings (SPOK) could be ideal investments to navigate through tough times…

Get all your
news in one place.

100's of premium titles.
One news app.

Al Jazeera

Walmart offers $3bn to settle lawsuits over role in opioid crisis

Tentative agreement would bring settlement total from lawsuits against various companies to more than $50bn.

Tribune News Service

Walmart agrees to pay $3.1B in opioid settlements after CVS and Walgreens’ $5B proposals

NEW YORK — Walmart agreed to pay $3.1 billion to resolve lawsuits accusing the pharmacy of selling drugs that contributed to the opioid epidemic, but denied the allegations and didn’t admit liability.

Reason

Biden's Student Loan Forgiveness Plan Is Unconstitutional, Says Federal Judge

Plus: Users surge on decentralized social media platform Mastodon, the fall of city drugstores, and more...

StockNews.com

1 Safe Stock You Can Buy and Hold Forever

Healthcare service provider CVS Health plans to venture into primary care after its Signify Health (SGFY) acquisition. Along with fundamental strength, the steady income stream offered by the company through dividends makes this stock a strong buy-and-hold-forever candidate. Read on….

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

Tribune News Service

Defense Department health plan cuts its pharmacy network by nearly 15,000 outlets

Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay but also has the option of using a regular pharmacy through Tricare, the Defense…

Chicago Sun-Times

Walgreens’ VillageMD buys another urgent and primary care chain for $9 billion

Walgreens and rival CVS have evolved in recent years far beyond their historic focus on store sales and filling prescriptions.

1 … 18 19 20 21

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.